grant

Examining Molecular Regulation of Unconventional Cytoplasmic Protein Secretion

Organization LOYOLA UNIVERSITY CHICAGOLocation MAYWOOD, UNITED STATESPosted 1 Aug 2021Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY20251-Phosphatidylinositol 3-KinaseAdipocytesAdipose CellAscotoxinAssayAutophagocytosisAutophagosomeBeta Proprotein Interleukin 1BindingBioassayBiochemicalBiologicalBiological AssayBiological FunctionBiological ProcessBiologyBlood monocyteBrefeldin AC 2aC2aCRISPR approachCRISPR based approachCRISPR editing screenCRISPR methodCRISPR methodologyCRISPR screenCRISPR techniqueCRISPR technologyCRISPR toolsCRISPR-CAS-9CRISPR-based methodCRISPR-based screenCRISPR-based techniqueCRISPR-based technologyCRISPR-based toolCRISPR/CAS approachCRISPR/Cas methodCRISPR/Cas technologyCRISPR/Cas9CRISPR/Cas9 screenCRISPR/Cas9 technologyCas nuclease technologyCell BodyCell membraneCellsClustered Regularly Interspaced Short Palindromic Repeats approachClustered Regularly Interspaced Short Palindromic Repeats methodClustered Regularly Interspaced Short Palindromic Repeats methodologyClustered Regularly Interspaced Short Palindromic Repeats techniqueClustered Regularly Interspaced Short Palindromic Repeats technologyCyaneinCytolysisCytoplasmCytoplasmic MembraneCytoplasmic ProteinDataDecumbinDestinationsDiseaseDisorderEndoplasmic ReticulumEndosomesErgastoplasmExtracellular SpaceFat CellsFluorescence Light MicroscopyFluorescence MicroscopyFoundationsGenesGoalsGolgiGolgi ApparatusGolgi ComplexGrowth AgentsGrowth FactorGrowth SubstancesIL-1 betaIL-1 βIL-1-bIL-1βIL1-BetaIL1-βIL1B ProteinIL1F2IL1βInflammation MediatorsInflammatory ResponseInnate ImmunityInositide PhospholipidsInositol PhosphoglyceridesInositol PhospholipidsIntercellular SpaceInterleukin 1betaInterleukin-1 betaInterleukin-1βInvestigatorsKidneyKidney Urinary SystemKinasesLipidsLipocytesLysisMarrow monocyteMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMature LipocyteMature fat cellMembraneMentorsMethodologyMethodsMolecularMolecular GeneticsMolecular InteractionNative ImmunityNatural ImmunityNerve CellsNerve UnitNeural CellNeurocyteNeuronsNon-Specific ImmunityNonspecific ImmunityOrganellesPI-3 KinasePI3-KinasePI3CGPI3KGammaPI3kPIK3PIK3CGPIK3CG genePathogenicityPathway interactionsPeptide Signal SequencesPhosphatasesPhosphatidyl InositolPhosphatidylinositol 3-KinasePhosphatidylinositol-3-OH KinasePhosphatidylinositolsPhosphohydrolasesPhosphoinositide 3-HydroxykinasePhosphoinositidesPhosphomonoesterasesPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferase GenePhosphotransferasesPlasma MembranePlayPreinterleukin 1 BetaProcessProtein BiosynthesisProtein PhosphorylationProtein SecretionProtein TraffickingProteinsProteins Growth FactorsProteomicsPtdInsPtdIns 3-KinaseReceptosomesRegulationResearchResearch PersonnelResearchersResistanceRibosomal Peptide BiosynthesisRibosomal Protein BiosynthesisRibosomal Protein SynthesisRoleRouteSecretory GranulesSecretory VesiclesSignal PeptideSignal SequencesSynergisidinSystemTestingTrainingTransphosphorylasesType I Phosphatidylinositol KinaseType III Phosphoinositide 3-KinaseWorkangiogenesisautophagybiologicblood vessel developmentblood vessel formationcell typeclustered regularly interspaced short palindromic repeats screencomplement 2acomplement C2acomplement C2a fragmentcytokinedrug developmentexperimentexperimental researchexperimental studyexperimentsfatty acid-binding proteinsfunctional genomicsgenome scalegenome-widegenomewidehepatoma cellhuman diseaseinflammatory mediatorinterestmembrane structuremonocyteneuronalnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovelnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel therapeutic targetnovel therapy targetpathwaypharmacologicplasmalemmaprogramsprotein signal sequenceprotein synthesisprotein transportrenalresistantresponsesocial rolestressortargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttool
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract/Project Summary
Secreted proteins serve a variety of critical biological roles and thus, the molecular regulation of protein secretion

is intensively investigated. Many elegant studies have revealed conserved molecular principles underlying the

classical secretory pathway. Proteins bearing signal peptides are co-translationally inserted into the endoplasmic

reticulum (ER) where they are properly folded, transported to the Golgi apparatus, and packaged into secretory

vesicles for export to various intracellular destinations or fusion with the plasma membrane to enable protein

secretion into the extracellular space. However, over the past two decades, several cytoplasmic proteins involved

in innate immunity, angiogenesis, and neuronal pathogenicity have been shown to be secreted via ER-Golgi

independent, unconventional secretory routes. Thus, given the broad biological utility of unconventional

cytoplasmic protein secretion (UCPS), understanding the molecular regulation of the process is of considerable

interest. To this end, I developed a genome-scale CRISPR screen to identify novel regulators of UCPS. My

preliminary work has identified a class II phosphatidylinositol-3-kinase (PI3K-C2α) as a regulator of the secretion

of interleukin-1β, an unconventionally secreted cytokine that plays a major role in the inflammatory response.

Furthermore, I have developed a mass-spectrometry based method that can identify unconventionally secreted

proteins in a high-throughput, unbiased manner. My proposal will apply cutting-edge molecular genetic and

proteomic tools to uncover the breadth of secreted proteins that use UCPS pathways in diverse cell types (Aim

1), and to characterize the role of PI3K-C2α in modulating UCPS (Aim 2). Furthermore, the CRISPR screening

strategy that will be used in Aim 2 may identify novel regulators of UCPS. Together, these studies will address

my central hypothesis that UCPS operates in diverse cell types, and is regulated by a conserved molecular

machinery that supports the secretion of functionally diverse, signal-peptide lacking proteins. This research will

be conducted under the guidance of my primary mentor and mentoring committee, who are experts in the fields

of molecular genetics, protein trafficking, phosphoinositide biology, and proteomics. Their technical, academic,

and professional guidance will allow me to successfully complete the proposed experiments, and help me

transition to independence. As an independent investigator, the long-term goal of my research program will be

to decipher the mechanisms by which the secretory pathway adapts to intrinsic and extrinsic stressors, and

characterize the maladaptive responses that contribute to disease states.

Grant Number: 5R00GM141268-05
NIH Institute/Center: NIH

Principal Investigator: Prabhodh Abbineni

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →